“Basically, your skin sees sunlight and freaks out a bit – it can get itchy, bumpy, red, rashy [and] sometimes even hive-like ...

Tretinoin cream can be considered in treating multiple miliary osteoma cutis of the face, especially when dealing with small and superficial lesions (Cohen, Chetov, Cagnano, Naimer, & Vardy, 2001).

Hydrocortisone cream (0.5% or 1.0%): Quells itching and inflammation associated with sun rash. Oral antihistamines: Taking Benadryl or Zyrtec can help manage itchiness. Pain relievers: Analgesics like ...

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

WILMINGTON, Del., June 20, 2025--Update on FDA Review of Ruxolitinib Cream (Opzelura) for Children Ages 2-11 with Atopic Dermatitis ...

opic dermatitis” Open Label Extension (INTEGUMENT-OLE) was a Phase 3, multicenter, open-label extension study of the long-term safety of roflumilast cream 0.15% in adults and children ages 6 ...

New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no ...

Zoryve cream helped 63.1% of children aged 2–5 reach vIGA-AD 0/1 after 56 weeks. Only 2.5% of kids aged 2–5 experienced treatment-related side effects in the study. Market-moving news hits ...

ZORYVE (roflumilast) cream 0.15% is approved by the FDA for the topical treatment of mild to moderate atopic dermatitis in patients 6 years of age and older.

Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference Provided by GlobeNewswire Jun 6, 2025, 5:00:00 AM ...

New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or ...